![]() |
市場調查報告書
商品編碼
1370634
醫療輻射檢測市場規模(按類型(充氣偵測器、閃爍體、固態)、按產品(個人劑量計、區域過程劑量計、表面污染監測儀)、最終用途 - 全球預測,2023-2032 年Medical Radiation Detection Market Size By Type (Gas-filled Detectors, Scintillators, Solid-State), By Product (Personal Dosimeters, Area Process Dosimeters, Surface Contamination Monitors), By End-use - Global Forecast, 2023-2032 |
2023年至2032年,全球醫療輻射檢測市場的年複合成長率將達到7.4%。醫療設備和成像輻射領域不斷成長的研究和開發為市場提供了支持。例如,2023年9月,一群科學家與美國能源部阿貢國家實驗室合作,成功展示了一種新型探測器材料在探測高能量X光散射圖案方面的出色性能。即使在極高的 X光通量下,這種材料也表現出卓越的耐用性,並提供了具有成本效益的解決方案,使其成為基於同步加速器的 X光研究的寶貴資產。
隨著該領域不斷創新,重點是提高醫療程序的安全性和準確性,對更複雜、更有效率的輻射檢測技術的需求將呈上升趨勢。人們對研發的興趣日益濃厚,正在推動醫療輻射檢測市場的成長,最終有利於病患照護和醫療保健結果。
整個醫療輻射檢測市場根據產品、最終用途和地區進行分類。
區域製程劑量計領域將在 2023 年至 2032 年間經歷重大發展。這些專用設備對於監測和保護輻射密集環境(例如醫療機構和工業環境)中的個人至關重要。隨著人們對工人和病人安全的日益重視,對精確可靠的區域過程劑量計的需求不斷增加,使其成為醫療輻射檢測市場佔有率的重要組成部分。
門診手術中心部分從 2023 年到 2032 年將實現顯著的年複合成長率。隨著這些中心執行越來越多的放射學手術,確保患者和醫療保健專業人員的安全至關重要。因此,門診手術中心對輻射檢測設備的需求增加,在效率和患者護理是首要任務的環境中提供重要的保護和合規性。因此,不斷成長的患者偏好和經濟效益支持了門診手術中心細分市場對醫療輻射檢測市場需求的貢獻。
歐洲醫療輻射檢測市場從 2023 年到 2032 年將呈現可觀的年複合成長率。這一成長可歸因於嚴格的安全法規和醫療保健環境中輻射風險意識的不斷增強。隨著對患者和工作人員安全的關注,對準確、可靠的輻射檢測解決方案的需求日益增加,特別是隨著該地區推出的醫療診斷設備數量不斷增加。
例如,2023 年 10 月,價值 3,200 萬英鎊的用於藥物發現的開創性全身正子斷層掃描 (PET) 影像平台亮相。這項開創性的舉措在英國尚屬首次,是透過 Medicines Discovery Catapult (MDC)、醫學研究委員會 (MRC) 之間的合作以及創新英國的支持而得以實現,所有這些都由 UKRI 基礎設施基金資助。隨著歐洲繼續優先考慮輻射安全,該地區的醫療輻射檢測市場正在持續成長。
Global Medical Radiation Detection Market will witness 7.4% CAGR between 2023 and 2032. The growing research and development in the field of radiation in medical devices and imaging supports the market. For instance, in September 2023, a team of scientists collaborating with the US Department of Energy's Argonne National Laboratory successfully demonstrated a new detector material's outstanding performance in detecting high-energy X-ray scattering patterns. This material exhibits remarkable durability even under extremely high X-ray flux and offers a cost-effective solution, making it a valuable asset for synchrotron-based X-ray research.
As the field continues to innovate with a focus on enhancing safety and accuracy in medical procedures, the demand for more sophisticated and efficient radiation detection technologies will record an upward trend. This growing interest in R&D is driving the medical radiation detection market growth, ultimately benefiting patient care and healthcare outcomes.
The overall Medical Radiation Detection Market is classified based on product, end-use, and region.
Area process dosimeters segment will undergo significant development from 2023 to 2032. These specialized devices are crucial for monitoring and safeguarding individuals in radiation-intensive environments, such as healthcare facilities and industrial settings. With a growing emphasis on worker and patient safety, the demand for precise and reliable area process dosimeters is on the rise, making them an essential component in the medical radiation detection market share.
Ambulatory surgery centers segment will register a notable CAGR from 2023 to 2032. As these centers perform a growing number of radiological procedures, ensuring the safety of patients and healthcare professionals is paramount. Consequently, the demand for radiation detection devices in ambulatory surgery centers has increased, providing a vital layer of protection and compliance in an environment where efficiency and patient care are top priorities. Therefore, the growing patient preference and economic benefits support the contribution of the ambulatory surgery centers segment in the medical radiation detection market demand.
Europe medical radiation detection market will showcase an appreciable CAGR from 2023 to 2032. This increase can be attributed to stringent safety regulations and growing awareness of radiation risks in healthcare settings. With a focus on patient and staff safety, there's a heightened need for accurate and reliable radiation detection solutions, especially with the rising number of medical diagnosis device launches in the region.
For instance, in October 2023, A pioneering total-body positron emission tomography (PET) imaging platform for drug discovery worth £32 million has been unveiled. This groundbreaking initiative, the first of its kind in the UK, has been made possible through collaboration between the Medicines Discovery Catapult (MDC), the Medical Research Council (MRC), and the support of Innovate UK, all funded by the UKRI Infrastructure fund. As Europe continues to prioritize radiation safety, the medical radiation detection market in the region is experiencing sustained growth.